Xiaotao Huang

机构：The University of Texas MD Anderson Cancer Center, Dongguan People’s Hospital

发表论文 34 篇 · 总被引 707 次 · h-index 16

代表论文

• Neoadjuvant toripalimab combined with gemcitabine and cisplatin in resectable locally advanced head and neck squamous cell carcinoma (NeoTGP01): An open label, single-arm, phase Ib clinical trial (2022 · Journal of Experimental & Clinical Cancer Research · 被引 75)
• Geniposidic acid protected against ANIT-induced hepatotoxity and acute intrahepatic cholestasis, due to Fxr-mediated regulation of Bsep and Mrp2 (2015 · Journal of Ethnopharmacology · 被引 70)
• Comparisons between Direct Anterior Approach and Lateral Approach for Primary Total Hip Arthroplasty in Postoperative Orthopaedic Complications: A Systematic Review and Meta‐Analysis (2021 · Orthopaedic Surgery · 被引 51)
• Activating the pregnane X receptor by imperatorin attenuates dextran sulphate sodium‐induced colitis in mice (2018 · British Journal of Pharmacology · 被引 51)
• Hypoxia-Induced lncRNA-NEAT1 Sustains the Growth of Hepatocellular Carcinoma via Regulation of miR-199a-3p/UCK2 (2020 · Frontiers in Oncology · 被引 50)
• Prevention of cholesterol gallstone disease by schaftoside in lithogenic diet-induced C57BL/6 mouse model (2017 · European Journal of Pharmacology · 被引 50)